Biomarkers for gastric cancer: molecular classification revisited
Gastric cancer (GC) is one of the most common lethal cancer worldwide. In recent years, several new targeted therapeutic agents for the treatment of metastatic GC have been developed. These include drugs that block human epidermal growth factor receptor 2 (HER2) or epidermal growth factor receptor,...
Main Authors: | Jeeyun Lee, Kyoung-Mee Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Sungkyunkwan University School of Medi
2017-06-01
|
Series: | Precision and Future Medicine |
Subjects: | |
Online Access: | http://www.pfmjournal.org/upload/pdf/pfm-2017-00079.pdf |
Similar Items
-
Combined biomarker for prediction of response to an immune checkpoint inhibitor in metastatic gastric cancer
by: You Jeong Heo, et al.
Published: (2019-12-01) -
Kyoto Classification of Gastritis and Gastric Cancer
by: Dong Hyun Lee
Published: (2019-06-01) -
The Effect of Helicobacter pylori Infection on Recurrence of Gastric Hyperplastic Polyp after Endoscopic Removal
by: Kyu Ho Kang, et al.
Published: (2018-04-01) -
Endoscopic Submucosal Dissection of an Inverted Early Gastric Cancer-Forming False Gastric Diverticulum
by: Yong-il Lee, et al.
Published: (2016-01-01) -
Neutrophil-lymphocyte ratio change after curative gastrectomy for gastric cancer: a subgroup analysis
by: Daniel José Szor, et al.
Published: (2019-11-01)